Drug Information

Drug General Information
Drug ID
D02JEW
Former ID
DIB015410
Drug Name
GSK-2130579A
Synonyms
Leukemia vaccine, GlaxoSmithKline; WT1 ASCI, GlaxoSmithKline; WT1 antigen specific cancer immunotherapeutic, GlaxoSmithKline; WT1 vaccine, GlaxoSmithKline
Drug Type
Vaccine
Indication Acute myeloid leukemia [ICD9: 205; ICD10:C92.0] Phase 1 [522918]
Company
Glaxosmithkline
Target and Pathway
Target(s) Wilms' tumor protein Target Info [550079]
KEGG Pathway Transcriptional misregulation in cancer
NetPath Pathway FSH Signaling Pathway
IL5 Signaling Pathway
Pathway Interaction Database p73 transcription factor network
Regulation of Telomerase
WikiPathways Primary Focal Segmental Glomerulosclerosis FSGS
Integrated Pancreatic Cancer Pathway
References
Ref 522918ClinicalTrials.gov (NCT01051063) Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy. U.S. National Institutes of Health.
Ref 550079Spoilight on personalized medicine. A pharma matters report, Thomson Reuters, 2012.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.